Targeted depletion of activated fibroblasts via [177Lu]Lu-FAPI radionuclide therapy ameliorates bleomycin-induced lung fibrosis
IntroductionFibroblast activation protein (FAP)-targeted radiopharmaceuticals have been widely applied in oncologic imaging and therapy, while their application in pulmonary fibrosis remains underexplored. This study investigated the biodistribution an…